4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001236927-25-000007
Director sold 129,172 shares at an average $370.24 ($47,825,149)
- Director acquired 129,172 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2025-08-13 | Option exercise 10b5-1 | +129,172 | $9.45 | $1,220,675 | 316,336 | D: show line 1 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −1,600 | $358.23 | $573,171 | 314,736 | D: show line 2 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −455 | $359.31 | $163,485 | 314,281 | D: show line 3 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −3,153 | $360.27 | $1,135,938 | 311,128 | D: show line 4 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −1,754 | $361.13 | $633,424 | 309,374 | D: show line 5 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −1,439 | $362.29 | $521,332 | 307,935 | D: show line 6 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −2,591 | $363.08 | $940,731 | 305,344 | D: show line 7 in the form |
| FRIEDMAN PAUL A Director | 2025-08-13 | Sale 10b5-1 | −3,529 | $364.02 | $1,284,639 | 301,815 | D: show line 8 in the form |
| Open-market sales · 129,172 sh · avg $370.24 · $47,825,149 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2025-08-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −129,172 | 0 | D: show line 19 in the form |
Loading xslF345X05/wk-form4_1755123534.xml…